leisure time -WSS

leisure time

author：hotspot 2025-08-26 03:42:23 - browse：2987

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： FDA seeks to regulate lab

WSS

Listen: Who gets the credit for GLP

Mindstrong's demise and the future of mental health care

Did you have Obamacare on your GOP debate bingo card?

Better Therapeutics data on benefit with GLP

FDA advisers vote against ALS treatment from BrainStorm

Eight reasons why you should get an updated Covid vaccine

explore

leisure time

focus

Medical records are filled with copy

Inequities make cancer less preventable for women: report

Trump demands the U.S. pay no more for drugs than other countries … again

Better Therapeutics data on benefit with GLP

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What the Wegovy shortage looks like for doctors — and for patients

Psychedelics group wrestles with new pharma identity

Readout LOUD podcast: Merger Mondays, Ozempic panic

How one medical school became remarkably diverse

FDA advisers vote against ALS treatment from BrainStorm

knowledge

Address the ethical violations that led to 'Three Identical Strangers'

Humana CEO Bruce Broussard to step down in 2024

Paxlovid should be available without a positive Covid test

Humana CEO Bruce Broussard to step down in 2024

WHO recommends dropping component of many flu vaccines

Researchers use wearables data and AI to predict preterm birth risk

focus

focus

entertainment

focus